Xuefei Ji

1.1k total citations
44 papers, 957 citations indexed

About

Xuefei Ji is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Xuefei Ji has authored 44 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Physiology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Xuefei Ji's work include Alzheimer's disease research and treatments (18 papers), Mitochondrial Function and Pathology (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Xuefei Ji is often cited by papers focused on Alzheimer's disease research and treatments (18 papers), Mitochondrial Function and Pathology (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Xuefei Ji collaborates with scholars based in China, France and Japan. Xuefei Ji's co-authors include Libo Zou, Tianyan Chi, Ge Jin, Qian Xu, Lihua Wang, Peng Liu, Peng Liu, Danyang Liu, Yue Qi and Zhou Xiao-yu and has published in prestigious journals such as Molecules, Chemical Science and Psychopharmacology.

In The Last Decade

Xuefei Ji

42 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefei Ji China 23 509 301 209 202 169 44 957
Tianyan Chi China 22 484 1.0× 297 1.0× 203 1.0× 200 1.0× 170 1.0× 35 915
Nesrine S. El Sayed Egypt 24 414 0.8× 256 0.9× 121 0.6× 198 1.0× 178 1.1× 59 1.2k
Huanmin Luo China 16 306 0.6× 260 0.9× 165 0.8× 150 0.7× 102 0.6× 58 788
Sravan Gopalkrishnashetty Sreenivasmurthy Hong Kong 22 424 0.8× 452 1.5× 124 0.6× 163 0.8× 227 1.3× 30 1.2k
Yuki Takada‐Takatori Japan 21 707 1.4× 209 0.7× 248 1.2× 274 1.4× 355 2.1× 43 1.3k
Aaina Singh Rathore India 14 437 0.9× 217 0.7× 229 1.1× 176 0.9× 123 0.7× 20 1.1k
Leonardo Guzmán‐Martínez Chile 12 320 0.6× 402 1.3× 131 0.6× 337 1.7× 135 0.8× 19 1.0k
Rupinder Kaur Sodhi India 19 368 0.7× 226 0.8× 107 0.5× 95 0.5× 131 0.8× 52 979
Xin Zhong China 14 329 0.6× 252 0.8× 74 0.4× 280 1.4× 139 0.8× 20 906

Countries citing papers authored by Xuefei Ji

Since Specialization
Citations

This map shows the geographic impact of Xuefei Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Ji more than expected).

Fields of papers citing papers by Xuefei Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefei Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Ji. The network helps show where Xuefei Ji may publish in the future.

Co-authorship network of co-authors of Xuefei Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefei Ji. A scholar is included among the top collaborators of Xuefei Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefei Ji. Xuefei Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Lei, et al.. (2025). Prognostic Values of Routine Clinical Tests in Adult Patients with Traumatic Brain Injury. World Neurosurgery. 195. 123637–123637.
2.
Wang, Yi, Liao Guan, Xuefei Ji, et al.. (2024). Nicotine restores olfactory function by activation of prok2R/Akt/FoxO3a axis in Parkinson’s disease. Journal of Translational Medicine. 22(1). 350–350. 5 indexed citations
4.
Zhang, Xian, Luxi Yang, Na Zheng, et al.. (2023). Mechanism of anti-AD action of OAB-14 by enhancing the function of glymphatic system. Neurochemistry International. 171. 105633–105633. 5 indexed citations
5.
Li, Pingping, Xuefei Ji, Yi Wang, et al.. (2023). Melatonin regulates microglial polarization to M2 cell via RhoA/ROCK signaling pathway in epilepsy. Immunity Inflammation and Disease. 11(6). e900–e900. 12 indexed citations
6.
7.
Liu, Danyang, Luxi Yang, Peng Liu, et al.. (2021). Sigma–1 receptor activation alleviates blood–brain barrier disruption post cerebral ischemia stroke by stimulating the GDNF–GFRα1–RET pathway. Experimental Neurology. 347. 113867–113867. 23 indexed citations
8.
Wang, Xiaojuan, et al.. (2021). PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer’s disease. Acta Pharmacologica Sinica. 43(8). 1916–1927. 27 indexed citations
9.
Jin, Ge, Lin Zhu, Peng Liu, et al.. (2019). Xanthoceraside prevented synaptic loss and reversed learning-memory deficits in APP/PS1 transgenic mice. The Journal of Physiological Sciences. 69(3). 477–488. 20 indexed citations
10.
Li, Yin-Jie, Pu Xu, Jiajing Shan, et al.. (2019). Interaction between hyperphosphorylated tau and pyroptosis in forskolin and streptozotocin induced AD models. Biomedicine & Pharmacotherapy. 121. 109618–109618. 42 indexed citations
11.
Liu, Danyang, Tianyan Chi, Xuefei Ji, et al.. (2018). Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in vascular dementia mice. Experimental Neurology. 308. 90–99. 25 indexed citations
12.
Liu, Peng, Rui Zhang, Danyang Liu, et al.. (2017). Time-course investigation of blood–brain barrier permeability and tight junction protein changes in a rat model of permanent focal ischemia. The Journal of Physiological Sciences. 68(2). 121–127. 38 indexed citations
13.
Xu, Qian, Xuefei Ji, Tianyan Chi, et al.. (2017). Sigma-1 receptor in brain ischemia/reperfusion: Possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor. Journal of the Neurological Sciences. 376. 166–175. 17 indexed citations
14.
Qi, Yue, Xuefei Ji, Tianyan Chi, et al.. (2017). Xanthoceraside attenuates amyloid β peptide 1-42 -induced memory impairments by reducing neuroinflammatory responses in mice. European Journal of Pharmacology. 820. 18–30. 26 indexed citations
15.
Zou, Libo, Peng Liu, Qian Xu, et al.. (2014). Xanthoceraside Induces Apoptosis in Melanoma Cells Through the Activation of Caspases and the Suppression of the IGF-1R/Raf/MEK/ERK Signaling Pathway. Journal of Medicinal Food. 17(10). 1070–1078. 18 indexed citations
16.
Jin, Ge, Lihua Wang, Xuefei Ji, et al.. (2014). Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice. Neuroscience Letters. 573. 58–63. 39 indexed citations
17.
Ji, Xuefei, Tianyan Chi, Qian Xu, et al.. (2014). Xanthoceraside Ameliorates Mitochondrial Dysfunction Contributing to the Improvement of Learning and Memory Impairment in Mice with Intracerebroventricular Injection of Aβ1‐42. Evidence-based Complementary and Alternative Medicine. 2014(1). 969342–969342. 31 indexed citations
19.
Wang, Lihua, et al.. (2009). Protective effects of xanthoceraside on learning and memory impairment induced by Aβ1-42 in mice.. 38(10). 734–736. 2 indexed citations
20.
Chi, Tianyan, Lihua Wang, Xuefei Ji, et al.. (2009). Protective effects of xanthoceraside on learning and memory impairment induced by Aβ25–35in mice. Journal of Asian Natural Products Research. 11(12). 1019–1027. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026